Some of the deadliest cancers are due to the lack of early detection, leaving cancer unchecked into late stages of disease. Here we focus on compelling nanomedicine solutions to address early cancer detection, especially for pancreatic and ovarian cancers. The panelists represent academic, clinical and industrial perspectives on developing novel, sensitive and reliable diagnostic tools for early cancer detection and to study normal vs. cancerous biological systems. We will present cuttingedge nanotechnology science and engineering contributing to innovative research in earlier cancer detection to ultimately provide more patient options and effective cancer treatments.

• Demonstrate how nanotechnology provides novel solutions for early disease detection and diagnosis
• Showcase multiplex strategies for more sensitive imaging, molecular diagnosis and targeted therapies
• Discuss the integration of bioinformatics and clinical information for accelerating targeted drug therapies